Transactions

Transactions

  • argenx SE is a clinical stage biotechnology company developing a deep pipeline of differentiated antibody based therapies for the treatment of severe autoimmune diseases and cancer.
  • Building on 30 years of experience in transfusion diagnostics, Quotient is a commercial stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced.
  • YETI Holdings, Inc. is a growing designer, marketer, and distributor of premium products for the outdoor and recreation market.
  • Cowen is pleased to announce that Worthington Industries, Inc. has partnered with Angeles Equity Partners to merge Worthington’s engineered cabs subsidiary with the newly acquired Crenlo Global to form Workhorse Cabs, LLC.
  • Contango Oil & Gas is a Houston, TX-based, independent upstream oil and gas company focused on exploring, developing, exploiting, producing, and acquiring crude oil and natural gas properties.
  • Oyster Point, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first in class pharmaceutical therapies to treat ocular surface diseases.
  • Cowen is pleased to announce that White Deer Energy has raised financing to support its acquisition of TorcSill Foundations, LLC as well as future working and growth capital needs of the platform.
  • Cabaletta Bio, Inc. is a pre clinical biotechnology company using proprietary technology to discover and develop chimeric autoantibody receptor, or CAAR, T cell product candidates for B cell mediated autoimmune diseases.
  • Cowen is pleased to announce that Gatekeeper Systems, Inc. has been acquired by Graham Partners.
  • Quarton, A Cowen Company advised Max Holder GmbH and its shareholders on the sale to the group of Alfred Kärcher SE & Co. KG.
  • Natera, Inc. operates an ISO 13485 certified and CAP accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif.
  • Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders that result in severe, life threatening metabolic disorders.
1 2 3 4 ...106 Next